1 / 70

IOL Chemicals and Pharmaceuticals Limited

IOL Chemicals and Pharmaceuticals Limited. Barnala. Geographical Location Map. Mile Stones Crossed. 1986 – IOLCP Established 1991 – Commenced Acetic Acid Production 1996 – Commissioned Ethyl Acetate Plant 1999 – Commenced Acetic Anhydride Production 2000 – Commissioned Ibuprofen Plant

Antony
Download Presentation

IOL Chemicals and Pharmaceuticals Limited

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IOL Chemicals and Pharmaceuticals Limited

  2. Barnala Geographical Location Map

  3. Mile Stones Crossed 1986 – IOLCP Established 1991 – Commenced Acetic Acid Production 1996 – Commissioned Ethyl Acetate Plant 1999 – Commenced Acetic Anhydride Production 2000 – Commissioned Ibuprofen Plant 2006 – Commissioned Power Cogeneration

  4. Product Range Active Pharmaceutical Ingredients Ibuprofen Proton Pump Inhibitors (PPI’s)(Proposed) Chemical Products Acetic Acid Ethyl Acetate Acetic Anhydride MCA & Acetyl Chloride IBB

  5. Capacity By Product Capacity ( TPA ) Acetic Acid Ethyl Acetate Acetic Anhydride Ibuprofen Products

  6. Revenues USD 20 mln USD 36 mln USD 48 mln USD 75 mln USD 70 mln Years

  7. Operating Profit USD 1.8 mln USD 3.8mln USD 3.9 mln USD 7.7 mln USD 7.2 mln Years

  8. Net Profit After Tax USD 0.53 mln USD 1.51 mln USD 1.57 mln USD 2.57 mln USD 2.64 mln Years

  9. Revenue Distribution By Product (%) Products

  10. Export Sales USD 0.41 mln USD 2.70mln USD 4.79 min USD 10.4 min USD 9.16mln Years

  11. GROWTH - Projects Under Implementation • Recently increased Ibuprofen capacity from 1800 TPA to 3600 TPA . • Currently implementing projects for Capacity Expansions, Forward & Backward Integration & Power Cogeneration, involving a capital expenditure of Rs 256 Crores (approx USD 53.3 million). • Commencing a new project for the production of PPI’s i.e. Rabiprazole, Omeprazole, Pantoprazole Esomeprazole and Lansoprazole in Jan 2010 at a cost of Rs 100 Crores ( approx USD 20.83 million).

  12. Under Implementation Projects Contd…

  13. Co-generation Expanding captive power cogeneration capacity to 17 MW, from 4 MW currently Present captive energy generation include Steam and Power Generation

  14. Monochloroacetic Acid & Acetyl ChlorideProcess Flow Acetic Anhydride Acetic Acid HCl Acetic Acid (By Product) Chlorine Gas HCl (By Product) Acetyl Chloride MCA

  15. Uses of Iso-Butyl Benzene IBB PLANT SPENTGAS IBB HIGH HYDRO CARBON LOW HYDRO CARBON POTASIUM CARBONATE THERMO PACK MARKET ACETIC ANHY DRIDE CAPTIVE CONSUMP TION CO- GEN ACETIC ANHY DRIDE ACETIC ANHY DRIDE MARKET THERMO PACK MARKET THE END PACK REUSE IN IBB PROCESS CO- GEN

  16. Projected Capacity Fiscal Year 2011-12 ALL OF THESE PROJECTS WILL HAVE TO BE FINANCED FROM INTERNAL ACCRUALS AND TERM DEBT WITHOUT FURTHER DILUTION IN EQUITY. THIS WILL RESULT IN SIGNIFICANT GROWTH IN PROFITABILITY AND EARNINGS PER SHARE

  17. Global Market Presence The various international markets catered till date include: 1.BANGLADESH 15.IRAN 29.SPAIN 43.ITALY 2.EGYPT 16.VEITNAM 30.PHILIPPINES 44.MAURITIUS 3.UGANDA 17.KUWAIT 31.CHILE 45.CHILE 4.SYRIA 18.GERMAN 32.ZIMBABWE 46.TAIWAN 5.AUSTRALIA 19.COLOMBIA 33.URUGUAY 47.TASMANIA 6.DUBAI 20.SINGAPORE 34.GHANA 48.OMAN 7.PAKISTAN 21.HONG KONG 35.TURKEY 49.COLOMBIA 8.THAILAND 22.MALAWI 36.CHINA 50.SOUTH AMERICA 9.MALAYSIA 23.BRAZIL 37.CONGO 51.YEMEN 10.BOLIVIA 24.SOUTH KOREA 38.SUDAN 11.MEXICO 25.PERU 39.NIGERIA 12.VENEZUELA 26.GUATEMALA 40.KENYA 13.ALGERIA 27.NEPAL 41.NEW ZEALAND 14.LATAVIA 28.DENMARK 42.SRI LANKA

  18. Our Products - Our Pride

  19. Non-Steroidal Anti – Inflammatory Drug (NSAID) Reduces Hormones Causing Inflammation & Pain in Body Usage in Treatment of Variety of Ailments Grades Available : - IP / BP /USP / EP /JP - Micronized - Dexibuprofen - DC ( Directly compressible ) Ibuprofen

  20. Applications & End Usage - Ibuprofen

  21. Indian Scenario - Ibuprofen

  22. Global Production – Ibuprofen

  23. Ibuprofen Production Capacities - IOLCP

  24. Ibuprofen - Market Share Domestic Market Global Market Indian Market 8000 MT per Annum Global Market 25,000 MT per Annum

  25. Acetic Acid • Acetic Acid or Ethanoic Acid Commonly Known as Vinegar • Sour Taste & Pungent Smell • Widely used as Chemical Reagent & Industrial Chemical • Derivatives application almost in all fields

  26. Applications & End Usage –Acetic Acid *IOLCP is Entering into the Manufacturing of MCA with the Capacity of 7200 TPA.

  27. Applications & End Usage- Acetic Acid

  28. Indian Scenario – Acetic Acid

  29. Global Production – Acetic Acid

  30. Acetic Acid Production Capacities - IOLCP

  31. Captive Consumption Vs Merchant Sales –Acetic Acid

  32. Acetic Acid – Market Share Domestic Market Global Market Indian Market 4,50,000 MT per Annum Global Market 92,00,000 MT per Annum

  33. Ethyl Acetate • Ethyl Acetate or Ethyl Ethanoate – Fragrant, Colorless Liquid • Diverse Industrial Application as Solvent • Usage as Synthetic Fruit Essence • Flavor in Pharmaceuticals • Coextractant of Camphor, Fats, Oils & Antibiotics • Ability to replace Aromatic Solvents like Toulene, Xylene & Methyl Isobutyl Ketone.

  34. Applications & End Usage – Ethyl Acetate

  35. Indian Scenario- Ethyl Acetate

  36. Global Production- Ethyl Acetate

  37. Ethyl Acetate Production Capacities - IOLCP

  38. Ethyl Acetate - Market Share Domestic Market Global Market Indian Market 1,90,000 MT per Annum Global Market 14,00,000 MT per Annum

  39. Acetic Anhydride • Ethanoic Anhydride or Acid Anhydride • Declared As “Controlled Substance” under the Narcotics Drugs & Psychotropic Substances (NDPS) Act 1985 by Narcotics Control Bureau, India • Usage in Pharmaceutical, Agrochemical, Dyes & Pigments, Cellulose Acetate Production

  40. Applications & End Usage-Acetic Anhydride *IOLCP is installing the Manufacturing Plant of Acetyl Chloride with the Capacity of 5200 TPA.

  41. Indian Scenario-Acetic Anhydride

  42. Global Production- Acetic Anhydride

  43. Acetic Anhydride Production Capacities - IOLCP

  44. Acetic Anhydride - Market Share Domestic Market Global Market Indian Market 55,000 MT per Annum Global Market 2,00,000 MT per Annum

  45. 1.Producing MCA without using hydrogenation. 2. MCA Plant is equipped with bubble cap graphite distillation Column instead of packed column. 3. Plant is equipped with Scrubbing System to take care of Environment Aspects. 4. In the Plant 900 critical parameters controlled by DCS for maintaining product quality and quantity Upcoming ProjectsMCA & Acetyl Chloride

  46. 5.Plant is based on forward and backward integration of existing products. 6.Acetyl Chloride is manufactured with HCL root instead of other root to reduce its cost and byproduct. 7.Process Parameters are designed using Simulation Software “CHEMCAD” Supplied by Chemstations USA. 8.Equipped with Teflon coated pipe and fitting to minimize maintenance problem. Contd..

  47. 1.IBB Plant is equipped with Pneumatic transfer System instead of pumps to save power. 2.In the Plant 1400 Critical parameters controlled by DCS to maintain product quality and Yield. 3.In the Plant Air Compressors are equipped with Variable Frequency toget Energy Efficiency. 4. IBB Plant is the Backward integration of existing product of IOLCP. Iso Butyl Benzene

  48. Manufacturing & Consumption(India) ( MCA, IBB, Acetyl Chloride )

  49. Manufacturer's in India…

  50. The company has planned for installation of new manufacturing facilities of PPIs- i.e. Rabiprazole, Omeprazole, Esomeprazole, Lansoprazole & Pantoprazole . Rabiprazole is used to treat conditions where the stomach produces too much acid, including ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. The total amount of Capital Expenditure will be about Rs 100 Crores ( approx USD 20.83 million). The Project of Rabiprazole is planned to be implemented from 2009-10. Upcoming Diversification PlansAnti-ulcerants- Proton Pump Inhibitors (PPI’s)

More Related